Shasun Pharmaceuticals has more than doubled its net profit at Rs.22.2 crore during the fourth quarter ended March 31, 2015, against Rs.10.4 crore reported in the corresponding quarter of the previous year. This is despite 3 per cent drop in turnover at Rs.336.1 crore for the quarter from Rs.346.6 crore in the fourth quarter of 2013-14. A company release says formulations business delivered robust growth in 2014-15 led by a strong performance in the regulated markets.
Business Line
By Srinath Rao, Senior Vice President, CitiusTech A few decades back, the purpose of watches…
Pharmapack Europe: 'Basel the best location for drug device innovation in Europe thanks to combination…
New Delhi, January 07, 2025: HMP virus can travel to the brain, or it can…
~ Co-authored by Dr Sanjith Saseedharan, Director-Critical Care, S. L. Raheja Hospital- A Fortis Associate…
Patients Embrace Flexibility with 37% of Online Doctor Consultations now happening even After 6 PM,…
Launches Advanced Pathology Laboratory Offering Over 2500+ Tests in collaboration with Parashar Pathology Clinic in…